Published November 2012 | Version v1
Journal article

Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients—Current state of image quality

  • 1. Department of Diagnostic and Interventional Radiology, Eberhard-Karls University Tübingen, Tübingen (Germany)
  • 2. Department of Nuclear Medicine and European Institute for Molecular Imaging, University of Münster, Münster (Germany)
  • 3. Department of Diagnostic and Interventional Neuroradiology, Eberhard-Karls University Tübingen, Tübingen (Germany)
  • 4. Laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens-Foundation, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls University Tübingen, Tübingen (Germany)
  • 5. Institute of Diagnostic and Interventional Radiology, University Hospital Zürich, Zürich (Switzerland)
  • 6. Department of Nuclear Medicine, Eberhard-Karls University Tübingen, Tübingen (Germany)

Description

Objectives: The present work illustrates the current state of image quality and diagnostic accuracy in a new hybrid BrainPET/MR. Materials and methods: 50 patients with intracranial masses, head and upper neck tumors or neurodegenerative diseases were examined with a hybrid BrainPET/MR consisting of a conventional 3T MR system and an MR-compatible PET insert. Directly before PET/MR, all patients underwent a PET/CT examination with either [18F]-FDG, [11C]-methionine or [68Ga]-DOTATOC. In addition to anatomical MR scans, functional sequences were performed including diffusion tensor imaging (DTI), arterial spin labeling (ASL) and proton-spectroscopy. Image quality score of MR imaging was evaluated using a 4-point-scale. PET data quality was assessed by evaluating FDG-uptake and tumor delineation with [11C]-methionine and [68Ga]-DOTATOC. FDG uptake quantification accuracy was evaluated by means of ROI analysis (right and left frontal and temporo-occipital lobes). The asymmetry indices and ratios between frontal and occipital ROIs were compared. Results: In 45/50 patients, PET/MR examination was successful. Visual analysis revealed a diagnostic image quality of anatomical MR imaging (mean quality score T2 FSE: 1.27 ± 0.54; FLAIR: 1.38 ± 0.61). ASL and proton-spectroscopy was possible in all cases. In DTI, dental artifacts lead to one non-diagnostic dataset (mean quality score DTI: 1.32 ± 0.69; ASL: 1.10 ± 0.31). PET datasets of PET/MR and PET/CT offered comparable tumor delineation with [11C]-methionine; additional lesions were found in 2/8 [68Ga]-DOTATOC-PET in the PET/MR. Mean asymmetry index revealed a high accordance between PET/MR and PET/CT (1.5 ± 2.2% vs. 0.9 ± 3.6%; mean ratio (frontal/parieto-occipital) 0.93 ± 0.08 vs. 0.96 ± 0.05), respectively. Conclusions: The hybrid BrainPET/MR allows for molecular, anatomical and functional imaging with uncompromised MR image quality and a high accordance of PET results between PET/MR and PET/CT. These results justify the application of this technique in further clinical studies and may contribute to the transfer into whole-body PET/MR systems.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ejrad.2011.12.027

Additional details

Identifiers

DOI
10.1016/j.ejrad.2011.12.027;
PII
S0720-048X(11)00895-3;

Publishing Information

Journal Title
European Journal of Radiology
Journal Volume
81
Journal Issue
11
Journal Page Range
p. 3472-3478
ISSN
0720-048X
CODEN
EJRADR

Optional Information

Copyright
Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.